Summary
This study investigated the modulatory effect of synthetic cannabinoids WIN55,212-2 on 5-HT3 receptor-activated currents (I5-HT3) in cultured rat trigeminal ganglion (TG) neurons using whole-cell patch clamp technique. The results showed that: (1) The majority of examined neurons (78.70%) were sensitive to 5-HT (3–300 μmol/L). 5-HT induced inward currents in a concentration-dependent manner and the currents were blocked by ICS 205-930 (1 μmol/L), a selective antagonist of the 5-HT3 receptor; (2) Pre-application of WIN55,212-2 (0.01–1 μmol/L) significantly inhibited I5-HT3 reversibly in concentration-dependent and voltage-independent manners. The concentration-response curve of 5-HT3 receptor was shifted downward by WIN55,212-2 without any change of the threshold value. The EC50 values of two curves were very close (17.5±4.5) μmol/L vs. (15.2±4.5) μmol/L and WIN55,212-2 decreased the maximal amplitude of I5-HT3 by (48.65±4.15)%; (3) Neither AM281, a selective CB1 receptor antagonist, nor AM630, a selective CB2 receptor antagonist reversed the inhibition of I5-HT3 by WIN55,212-2; (4) When WIN55,212-2 was given from 15 to 120 s before 5-HT application, inhibitory effect was gradually increased and the maximal inhibition took place at 90 s, and the inhibition remained at the same level after 90 s. We are led to concluded that-WIN55,212-2 inhibited I5-HT3 significantly and neither CB1 receptor antagonist nor CB2 receptor antagonist could reverse the inhibition of I5-HT3 by WIN55,212-2. Moreover, WIN55,212-2 is not an open channel blocker (OCB) of 5-HT3 receptor. WIN55,212-2 significantly inhibited 5-HT-activated currents in a non-competitive manner. The inhibition of I5-HT3 by WIN55,212-2 is probably new one of peripheral analgesic mechanisms of WIN55,212-2, but the mechanism by which WIN55,212-2 inhibits I5-HT3 warrants further investigation.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Howlett, AC, Breivogel, CS, Childers SR, et al. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology. 2004,47(Suppl 1):345–358
Fan P. Cannabinoid agonists inhibits the activation of 5-HT3 receptors in rat nodose ganglion neurons. J Neurophysiol, 1995,73(2):907–910
Oz M, Zhang L, Morales M. Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes. Synapse, 2002,46(3):150–156
Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature, 1993,365(6441):61–65
Nocerino E, Amato M, Izzo AA. Cannabis and cannabinoid receptors. Fitoterapia, 2000,71(Suppl 1):S6–S12
Hohmann AG, Herkenham M. Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study. Neuroscience, 1999,90(3),923–931
Mazzari S, Canella R, Petrelli L, et al. N-(2-hydroxy-ethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol, 1996,300(3):227–236
Johanek LM, Heitmiller DR, Turner M, et al. Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms. Pain, 2001,93(3): 303–315
Martin WJ, Coffin PO, Attias E, et al. Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections. Brain Res, 1999,822(1–2): 237–242
Fox A, Kesingland, A, Gentry C, et al. The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain, 2001,92(1–2), 91–100
Hu WP, Li ZW, Ru Liqiang, et al. The characteristics of 5-hydroxytryptamine-activated current in rat trigeminal ganglion neurons. J Neuroanat (Chinese), 2004,20(6), 553–556
Hu WP, Guan BC, Ru LQ, et al. Potentiation of 5-HT3 receptor function by the activation of coexistent 5-HT2 receptors in trigeminal ganglion neurons of rats. Neuropharmacology, 2004,47(6), 832–840
Price TJ, Patwardhan A, Akopian AN, et al. Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55, 212-2 on trigeminal sensory neurons. Br J Pharmacol, 2004,142(2), 257–266
Shen JJ, Liu CJ, Li A, et al. Cannabinoids inhibited ATP-activated currents in rat trigeminal ganglionic neurons. Acta Physiologica Sinica, 2007,59(6)745–752
Zhou Y, Liu CJ, Li A, et al. Inhibition of GABA-activated Currents by Cannabinoids in Rat Trigeminal Neurons. Acta Med Univ Sci Technol Huazhong (Chinese), 2007,336(5):283–292
Lu YL, Liu CJ, Li A, et al. Cannabinoid inhibits nicotine-activated currents in rat trigeminal ganglion neurons. Stroke Nervl Dis (Chinese), 2005,12(5):272–242
Shi LJ, Liu LA, Cheng XH, et al. Modulation of neuronal nicotinic acetylcholine receptors by glucocorticoids. Acta Pharmacol Sin, 2002,23(3):237–242
PPertwee RG, Ross RA. Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids, 2002,66(2–3):101–121
Thomas BF, Compton DR, Martin BR. Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency. J Pharmacol Exp Ther, 1990,255(2): 624–630
Evans RM, Wease KN, MacDonald CJ, et al. Modulation of sensory neuron potassium conductances by anandamide indicates roles for metabolites. Br J Pharmacol, 2008,154(2):480–492
Vanegas H, Schaible HG. Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord. Prog Neurobiol, 2001,64(4):327–363
Vignali M, Benfenati V, Caprini M, et al. The endocannabinoid anandamide inhibits potassium conductance in rat cortical astrocytes. Glia, 2009,57(7):791–806
Lauckner JE, Jensen JB, Chen HY, et al. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci USA, 2008,105(7): 2699–2704
Waldeck-Weiermair M, Zoratti C, Osibow K, et al. Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression. J Cell Sci, 2008,121(Pt 10):1704–1717
Author information
Authors and Affiliations
Corresponding author
Additional information
The two authors contributed equally to the project.
This project was supported by National Natural Science Foundation of China (No. 30271500) & Science and Technology Research Project Fund from the Department of Education of Hubei Province of China (No. B20115101).
Rights and permissions
About this article
Cite this article
Shi, B., Yang, R., Wang, X. et al. Inhibition of 5-HT3 receptors-activated currents by cannabinoids in rat trigeminal ganglion neurons. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 32, 265–271 (2012). https://doi.org/10.1007/s11596-012-0047-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-012-0047-1